References
- Black, C. A. 1999. Delayed type hypersensitivity: Current theories with an historic perspective. Dermatol. Online J. 5:7
- Bretcher, P. A. 1994. Requirements and basis for efficaceous vaccination by a low antigen dose regimen against intracellular pathogens uniquely susceptible to cell-mediated attack. In: Strategies in Vaccine Design (Ada, G. L.). Austin, TX: RG Landes, pp. 99–112
- Bunn, T. L., Dietert, R. R., and Ladics, G. S. 2001a. Developmental immunotoxicology assessments in the rat: Age, gender, and strain comparisons after exposure to lead. Toxicol. Meth. 11:41–58
- Bunn, T. L., Parsons, P. J., Kao, E., and Dietert, R. R. 2001b. Exposure to lead during critical windows of embryonic development: Differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 64:57–66
- Burleson, G. R., Burleson, F. G., and Dietert, R. R. 2009. The cytotoxic T-lymphocyte (CTL) assay for evaluating cell-mediated immune function. In: Immunotoxicity Testing Series: Methods in Molecular Biology (Dietert, R. R.). Totowa, NJ: Humana press, Inc., pp. 199–205
- Burns-Naas, L. A., Hastings, K. L., Ladics, G. S., et al. 2008. What's so special about the developing immune system? Int. J. Toxicol. 27:223–254
- Chen, C. L., Wang, Y. M., Liu, C. F., et al. 2008. The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials 29:2173–2182
- Collinge, M., Burns-Naas, L. A., Chellman, G. J., et al. 2012. Developmental immunotoxicity (DIT) testing of pharmaceuticals: Current practices, state of the science, knowledge gaps, and recommendations. J. Immunotoxicol. 9:210--230
- Collinge, M., Burns-Naas, L. A., and Kawabata, T. T. 2010. Developmental immunotoxicology. In: Reproductive Toxicology. 6th ed. (Kapp, R. W., and Tyl, R. W.). New York: Informa Healthcare, pp. 134–156
- Dietert, R. R., and Burns-Naas, L. A. 2008. Developmental immunotoxicity in rodents. In: Immunotoxicology strategies for pharmaceutical safety assessment (Herzyk, D. J., and Bussiere, J. L.). Hoboken, NJ: John Wiley and Sons, Inc., pp. 273–297
- Dietert, R. R., and Holsapple, M. P. 2007. Methodologies for developmental immunotoxicity (DIT) testing. Methods 41:123–131
- Dietert, R. R., Lee, J. E., Olsen, J., et al. 2003. Developmental immunotoxicity of dexamethasone: Comparison of fetal versus adult exposures. Toxicology 194:163–176
- El-Gueddari, N. E., Rauchhaus, U., Moerschbacher, B. M., et al. 2002. Developmentally regulated conversion of surface exposed chitin to chitosan in cell walls of plant pathogenic fungi. New Phytol. 156:103–112
- Exon, J. H., Bussiere, J. L., and Mather, G. G. 1990. Immunotoxicity testing in the rat: An improved multiple assay model. Int. J. Immunopharmacol. 12:699–701
- Fadel, S., and Sarzotti, M. 2000. Cellular immune responses in neonates. Int. Rev. Immunol. 19:173–193
- Felse, P. A., and Panda, T. 1999. Studies on applications of chitin and its derivatives. Bioprocess Eng. 20:505–512
- Gehrs, B. C., and Smialowicz, R. J. 1999. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 134:79–88
- Henningsen, G. M., Koller, L. D., Exon, J. H., et al. 1984. A sensitive delayed-type hypersensitivity model in the rat for assessing in vivo cell-mediated immunity. J. Immunol. Meth. 70:153–165
- Herrmann, P., Schreier, M. H., Bazin, H., et al. 1988. Delayed-type hypersensitivity (DTH) in anti-IgM-treated B-cell-depleted mice: Analysis of induction and effector phase. Immunobiology 177:382–389
- Holsapple, M. P. 2002. Developmental immunotoxicology and risk assessment: A workshop summary. Hum. Exp. Toxicol. 21:473–478
- Holsapple, M. P., Burns-Naas, L. A., Hastings, K. L., et al. 2005. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol. Sci. 83:18–24
- Holsapple, M. P., Paustenbach, D. J., Charnley, G., et al. 2004. Symposium summary: Children's health risk – what's so special about the developing immune system? Toxicol. Appl. Pharmacol. 199:61–70
- Holsapple, M. P., van der Laan, J. W., and van Loveren, H. 2007. Development of a framework for developmental immunotoxicity (DIT) testing. In: Immunotoxicology and Immunopharmacology (Luebke, R. W., House, R., and Kimber, I.). Boca Raton, FL: CRC Press, pp. 347–361
- Hurtrel, B., Hurtrel, M., and Lagrange, P. H. 1984. Time course and histological differences between sheep red blood cells and tuberculin DTH reactions in mice. Ann. Immunol. (Paris) 135C:219–230
- Jerne, N. K., and Nordin, A. A. 1963. Plaque formation in agar by single antibody-producing cells. Science 140:405
- Karrow, N. A., Guo, T. L., Delclos, K. B., et al. 2004. Nonylphenol alters the activity of splenic NK cells and the numbers of leukocyte subpopulations in Sprague-Dawley rats: A two-generation feeding study. Toxicology 196:237–245
- Kaufmann, S. H., and Schaible, U. E. 2005. 100th anniversary of Robert Koch's Nobel Prize for the discovery of the tubercle bacillus. Trends Microbiol. 13:469–475
- Ladics, G. S., Smith, C., and Bunn, T. L. 2000. Characterization of an approach to developmental immunotoxicology assessment in the rat using SRBS as an antigen. Toxicol. Meth. 10:283–311
- Lagrange, P. H., and Mackaness, G. B. 1975. A stable form of delayed-type hypersensitivity. J. Exp. Med. 141:82–96
- Lagrange, P. H., Michel, J. C., Hurtrel, B., et al. 1980. Delayed-type hypersenstivity to sheep red blood cells in selected lines of mice with high or low antibody responses. Ann. Immunol. (Paris) 131C:257–277
- Lebrec, H., Blot, C., Pequet, S., et al. 1994. Immunotoxicological investigation using pharmaceutical drugs: in vivo evaluation of immune effects. Fundam. Appl. Toxicol. 23:159–168
- Lee, C. G. 2009. Chitin, chitinases and chitinase-like proteins in allergic inflammation and tissue remodeling. Yonsei Med. J. 50:22–30
- Lee, C. G., Da Silva, C. A., Lee, J. Y., et al. 2008. Chitin regulation of immune responses: An old molecule with new roles. Curr. Opin. Immunol. 20:684–689
- Luster, M. I., Dean, J. H., and Germolec, D. R. 2003. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111:579–583
- Luster, M. I., Munson, A. E., Thomas, P. T., et al. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2–19
- Mackaness, G. B., Lagrange, P. H., Miller, T. E., et al. 1974. Feedback inhibition of specifically sensitized lymphocytes. J. Exp. Med. 139:543–559
- Miller, T. E., Golemboski, K. A., Ha, R. S., et al. 1998. Developmental exposure to lead causes persistent immunotoxicity in F344 rats. Toxicol. Sci. 42:129–135
- Morikawa, Y., Kuribayashi, K., Yoshikawa, F., et al. 1991. Role of antibodies in the regulation of delayed-type hypersensitivity. Immunology 74:146–152
- Muzzarelli, R. A. 2010. Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar. Drugs 8:292–312
- Nghiem, D. X., Walterscheid, J. P., Kazimi, N., et al. 2002. Ultraviolet radiation-induced immunosuppression of delayed-type hypersensitivity in mice. Methods 28:25–33
- Piguet, P. F., Irle, C., Kollatte, E., et al. 1981. Post-thymic T-lymphocyte maturation during ontogenesis. J. Exp. Med. 154:581–593
- Plitnick, L. M., and Herzyk, D. J. 2010. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Methods Mol. Biol. 598:159–171
- Ramos, G., Nghiem, D. X., Walterscheid, J. P., et al. 2002. Dermal application of jet fuel suppresses secondary immune reactions. Toxicol. Appl. Pharmacol. 180:136–144
- Shibata, Y., Honda, I., Justice, J. P., et al. 2001. TH1adjuvant N-acetyl-D-glucosamine polymer up-regulates TH1 immunity but down-regulates TH2 immunity against a mycobacterial protein (MPB-59) in IL-10 knockout and wild-type mice. Infect. Immun. 69:6123–6130
- Shibata, Y., Metzger, W. J., and Myrvik, Q. N. 1997. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: Mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol. 159:2462–2467
- Smith, M. J., and White, K. L. Jr 2010. Establishment and comparison of delayed-type hypersensitivity models in the BCF mouse. J. Immunotoxicol. 7:308–317
- Spindler-Barth, M., and Buss, U. 1997. ELISA for determination of chitin and chitosan. In: Chitin Handbook (Muzzarelli, R. A., and Peter, M. G.). Grottammare, Italy: European Chitin Society
- Temple, L., Kawabata, T. T., Munson, A. E., et al. 1993. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:412–419
- Vos, J. G. 1980. Immunotoxicity assessment: Screening and function studies. Arch. Toxicol. Suppl. 4:95–108
- White, K. L. Jr., McLoughlin, C. E., Auttachoat, W., et al. 2012. Validation of the Candida albicans delayed-type hypersensitivity (DTH) model in the female B6C3F1 mouse for use in immunotoxicological investigations. J. Immunotoxicol. 9:141–147
- White, K. L. Jr., Musgrove, D. L., and Brown, R. D. 2010. The sheep erythrocyte T-dependent antibody response (TDAR). Methods Mol. Biol. 598:173–184
- Whittingham, S., Feery, B., and Mackay, I. R. 1982. Use of tetanus toxoid for testing cell-mediated immunity. Aust. N.Z. J. Med. 12:511–514